Investigating the Market Withdrawal: Why Was Betrixaban Discontinued?
•
3 min read
In June 2020, Portola Pharmaceuticals conducted a market withdrawal of Betrixaban (Bevyxxa) for business reasons, not due to specific safety or quality concerns. This article explores the clinical trial data, market challenges, and regulatory hurdles that answer the question: **Why was Betrixaban discontinued?**
